NCT01747486 · Interventional trial
Dose Optimization Trial of CD19 Redirected Autologous T Cells
Overall registry status Completed
Phase 2
Conditions Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
Delaware Valley sites
- Abramsonc Cancer Center of The University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory